Researcher.Life Logo

Research and Practice in Thrombosis and Haemostasis : Impact Factor & More

eISSN: 2475-0379pISSN: 2475-0379
JournalOpen Access

Key Metrics

CiteScore
5.8
Impact Factor
< 5
SJR
Q4Hematology
SNIP
1.41
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Research and Practice in Thrombosis and Haemostasis

Research and Practice in Thrombosis and Haemostasis Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Article-by-article
Article Processing ChargesUSD 2250
Publication Time7
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational Society on Thrombosis and Haemostasis
FrequencyArticle-by-article
Publication Start Year2017
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 7
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Research and Practice in Thrombosis and Haemostasis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Research and Practice in Thrombosis and Haemostasis

Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia &amp; bleeding
  • 1 May 2026
  • Research and Practice in Thrombosis and Haemostasis
MENSTRUAL OUTCOMES ARE FREQUENTLY OVERLOOKED IN VON WILLEBRAND DISEASE TRIALS
  • 1 May 2026
  • Research and Practice in Thrombosis and Haemostasis
Oral contraceptives and tissue factor expression. Comments on "Do combined oral contraceptives induce formation of tissue factor?": reply.
  • 1 Apr 2026
  • Research and practice in thrombosis and haemostasis
Health care resource utilization and costs of major bleeding in patients with and without dialysis-dependent end-stage kidney disease: a retrospective study.
  • 1 Mar 2026
  • Research and practice in thrombosis and haemostasis
The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopenia.
  • 1 Mar 2026
  • Research and practice in thrombosis and haemostasis
Adaption of the plasmin generation assay to enhance sensitivity to plasminogen activator inhibitor-1 and establishment of sex-specific reference values in human plasma.
  • 1 Mar 2026
  • Research and practice in thrombosis and haemostasis
Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia &amp; bleeding
  • 1 May 2026
  • Research and Practice in Thrombosis and Haemostasis
MENSTRUAL OUTCOMES ARE FREQUENTLY OVERLOOKED IN VON WILLEBRAND DISEASE TRIALS
  • 1 May 2026
  • Research and Practice in Thrombosis and Haemostasis
Oral contraceptives and tissue factor expression. Comments on "Do combined oral contraceptives induce formation of tissue factor?": reply.
  • 1 Apr 2026
  • Research and practice in thrombosis and haemostasis
Health care resource utilization and costs of major bleeding in patients with and without dialysis-dependent end-stage kidney disease: a retrospective study.
  • 1 Mar 2026
  • Research and practice in thrombosis and haemostasis
The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopenia.
  • 1 Mar 2026
  • Research and practice in thrombosis and haemostasis
Adaption of the plasmin generation assay to enhance sensitivity to plasminogen activator inhibitor-1 and establishment of sex-specific reference values in human plasma.
  • 1 Mar 2026
  • Research and practice in thrombosis and haemostasis

FAQs on Research and Practice in Thrombosis and Haemostasis